tiprankstipranks
Trending News
More News >
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market

Akero Therapeutics (AKRO) Ownership - Who Owns Akero Therapeutics?

Compare
584 Followers

Akero Therapeutics (AKRO) Ownership Overview

3.42%24.26%44.21%15.60%12.51%
44.21% Other Institutional Investors
15.60% ETFs
12.51% Public Companies and Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 84.07% of the company’s stock is owned by Institutional Investors, 3.42% is owned by Insiders, and 12.51% is owned by Public Companies and Individual Investors.
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 68.47% of the company’s stock is owned by Institutional Investors, 3.42% is owned by Insiders, and 15.60% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 27, 2025
xxxxxxxxxxxxx
$8786965
Mar 14, 2025
xxxxxxxxxxxxx
$27556
Mar 14, 2025
xxxxxxxxxxxxx
$78001
Mar 14, 2025
xxxxxxxxxxxxx
$23158

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$19460193
Mar 31, 2025
xxxxxxxxxxxxx
$22211902
Mar 31, 2025
xxxxxxxxxxxxx
$32099020

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,069,831Institution5.11%158,194,331
4,066,175Institution5.10%158,052,222
3,250,777Institution4.08%126,357,702
2,873,458Institution3.60%111,691,312
2,764,943Institution3.47%107,473,334
1,781,031Institution2.23%69,228,675
1,635,674Institution2.05%63,578,648
1,202,168Insider1.51%46,728,270
1,021,865Institution1.28%39,719,893
917,972Institution1.15%35,681,572

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,069,831Institution5.11%158,194,331
2,873,458Institution3.60%111,691,312
1,781,031Institution2.23%69,228,675
1,635,674Institution2.05%63,578,648
917,972Institution1.15%35,681,572
742,709Institution0.93%28,869,099
687,900Institution0.86%26,738,673
682,545Institution0.86%26,530,524
600,337Institution0.75%23,335,099
447,205Institution0.56%17,382,858

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,302,074Institution2.89%104,997,595
1,907,622Institution2.39%74,149,267
1,079,415Institution1.35%49,232,118
884,110Institution1.11%35,329,036
636,842Institution0.80%25,448,206
636,842Institution0.80%25,448,206
636,842Institution0.80%25,448,206
564,919Institution0.71%21,958,402
416,160Institution0.52%16,176,139
372,344Institution0.47%16,982,610

FAQ

Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately 44.21% of the company's stock is held by institutional investors, 3.42% is held by insiders, and 12.51% is held by retail investors.
    What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 44.21% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
      What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 12.51% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
        Who owns the most shares of Akero Therapeutics Inc (AKRO)?
        VANGUARD SPECIALIZED FUNDS owns the most shares of Akero Therapeutics Inc (AKRO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis